These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 20029960

  • 21. Crosstalk relationship between adiponectin receptors, PPAR-γ and α-adrenoceptors in renal vasculature of diabetic WKYs.
    Afzal S, Sattar MA, Eseyin OA, Attiq A, Johns EJ.
    Eur J Pharmacol; 2022 Feb 15; 917():174703. PubMed ID: 34973951
    [Abstract] [Full Text] [Related]

  • 22. HSF1 phosphorylation by ERK/GSK3 suppresses RNF126 to sustain IGF-IIR expression for hypertension-induced cardiomyocyte hypertrophy.
    Huang CY, Lee FL, Peng SF, Lin KH, Chen RJ, Ho TJ, Tsai FJ, Padma VV, Kuo WW, Huang CY.
    J Cell Physiol; 2018 Feb 15; 233(2):979-989. PubMed ID: 28383811
    [Abstract] [Full Text] [Related]

  • 23. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y, Zhu A, Yoneda T, Usukura M, Takata H, Yamagishi M.
    Am J Hypertens; 2007 Oct 15; 20(10):1119-24. PubMed ID: 17903697
    [Abstract] [Full Text] [Related]

  • 24. Prevention of hypertension by irbesartan in Dahl S rats relates to central angiotensin II type 1 receptor blockade.
    Leenen FH, Yuan B.
    Hypertension; 2001 Mar 15; 37(3):981-4. PubMed ID: 11244027
    [Abstract] [Full Text] [Related]

  • 25. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.
    Rose M, Balakumar P, Singh M.
    Pharmacology; 2007 Mar 15; 80(2-3):177-84. PubMed ID: 17570955
    [Abstract] [Full Text] [Related]

  • 26. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system.
    Leenen FH, White R, Yuan B.
    Am J Physiol Heart Circ Physiol; 2001 Dec 15; 281(6):H2410-6. PubMed ID: 11709406
    [Abstract] [Full Text] [Related]

  • 27. Altered signal transduction system in hypertrophied myocardium: angiotensin II stimulates collagen synthesis in hypertrophied hearts.
    Kawaguchi H, Kitabatake A.
    J Card Fail; 1996 Dec 15; 2(4 Suppl):S13-9. PubMed ID: 8951556
    [Abstract] [Full Text] [Related]

  • 28. The renin-angiotensin system and experimental heart failure.
    Wollert KC, Drexler H.
    Cardiovasc Res; 1999 Sep 15; 43(4):838-49. PubMed ID: 10615411
    [Abstract] [Full Text] [Related]

  • 29. Blockade of angiotensin II type 1 receptor diminishes cardiac hypertrophy, but does not abolish thyroxin-induced preconditioning.
    Pantos C, Paizis I, Mourouzis I, Moraitis P, Tzeis S, Karamanoli E, Mourouzis C, Karageorgiou H, Cokkinos DV.
    Horm Metab Res; 2005 Aug 15; 37(8):500-4. PubMed ID: 16138263
    [Abstract] [Full Text] [Related]

  • 30. Two angiotensin AT1 receptor antagonists, irbesartan and losartan, effects in cholesterol-fed rabbits.
    Sanz M, Ganado P, Tejerina T.
    Eur J Pharmacol; 2002 May 03; 442(1-2):99-106. PubMed ID: 12020687
    [Abstract] [Full Text] [Related]

  • 31. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats.
    Mizuno K, Tani M, Hashimoto S, Niimura S, Sanada H, Watanabe H, Ohtsuki M, Fukuchi S.
    Life Sci; 1992 May 03; 51(5):367-74. PubMed ID: 1385640
    [Abstract] [Full Text] [Related]

  • 32. The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
    Babiker F, Al-Jarallah A, Joseph S.
    PLoS One; 2016 May 03; 11(11):e0165777. PubMed ID: 27814397
    [Abstract] [Full Text] [Related]

  • 33. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7).
    Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, Machado JM, Speth RC, Raizada MK, Katovich MJ.
    Am J Physiol Heart Circ Physiol; 2007 Feb 03; 292(2):H736-42. PubMed ID: 17098828
    [Abstract] [Full Text] [Related]

  • 34. Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure.
    Watanabe R, Suzuki J, Wakayama K, Kumagai H, Ikeda Y, Akazawa H, Komuro I, Isobe M.
    Hypertens Res; 2016 Apr 03; 39(4):237-44. PubMed ID: 26657004
    [Abstract] [Full Text] [Related]

  • 35. Elevated dietary sodium intake exacerbates myocardial hypertrophy associated with cardiac-specific overproduction of angiotensin II.
    Porrello ER, Huggins CE, Curl CI, Domenighetti AA, Pedrazzini T, Delbridge LM, Morgan TO.
    J Renin Angiotensin Aldosterone Syst; 2004 Dec 03; 5(4):169-75. PubMed ID: 15806712
    [Abstract] [Full Text] [Related]

  • 36. Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodeling post-myocardial infarction ventricle.
    Ambrose J, Pribnow DG, Giraud GD, Perkins KD, Muldoon L, Greenberg BH.
    J Cardiovasc Pharmacol; 1999 Mar 03; 33(3):433-9. PubMed ID: 10069680
    [Abstract] [Full Text] [Related]

  • 37. Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice.
    Duan SZ, Ivashchenko CY, Russell MW, Milstone DS, Mortensen RM.
    Circ Res; 2005 Aug 19; 97(4):372-9. PubMed ID: 16051889
    [Abstract] [Full Text] [Related]

  • 38. [Inhibitory effect on activated renin-angiotensin system by astragaloside IV in rats with pressure-overload induced cardiac hypertrophy].
    Shi H, Ma C, Liu Y, Zhou J, Hu Z, Wu D.
    Zhongguo Zhong Yao Za Zhi; 2009 Dec 19; 34(24):3242-6. PubMed ID: 20353010
    [Abstract] [Full Text] [Related]

  • 39. TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats.
    Mizuno K, Niimura S, Katoh K, Fukuchi S.
    Life Sci; 1994 Dec 19; 54(25):1987-94. PubMed ID: 8201847
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.